Medical Xpress December 8, 2021
Rutgers Cancer Institute of New Jersey

Artificial intelligence/machine learning involves the development of computer systems that perform tasks that would normally require human intelligence. AI/ML is used by people every day, for example, while using smart home devices or digital voice assistants. The use of AI/ML is also rapidly growing in biomedical research and health care. In a recent viewpoint paper, investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) explored how AI/ML will complement existing approaches focused on genome-protein sequence information, including identifying mutations in human tumors.

Stephen K. Burley, MD, DPhil, and collaborators published the study December 2 in the New England Journal of Medicine.

What is the potential of AI/MI in cancer research and clinical practice?

We...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Provider, Technology
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.
AI degrades our work, nurses say
What If Generative AI Turned To Be A Flop In Healthcare?
A.C.C.E.S.S. AI: A New Framework For Advancing Health Equity In Health Care AI

Share This Article